Clinical Trial Update: Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating Celecoxib for preventing basal cell carcinomas in Basal Cell Nevus Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Basal Cell Nevus Syndrome

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: University of California, San Francisco | Conditions: Non-melanomatous Skin Cancer | Phase 2 | Status: COMPLETED